Product Code: IRTNTR3216
TechNavio's analysts forecast the OTC Pharmaceuticals Market in Latin America
market to grow at a CAGR of 14.54 percent over the period 2013-2018. One of
the key factors contributing to this market growth is the increasing switch
from prescription to OTC drugs. The OTC Pharmaceuticals Market in Latin
America has also been witnessing the some key increased outsourcing of drug
development activities. However, the stringent regulations are expected to
pose a challenge to the growth of this market.
TechNavio's report, the OTC Pharmaceuticals Market in Latin America Market
2014-2018, has been prepared based on an in-depth market analysis with inputs
from industry experts. The report covers Americas, EMEA, and APAC; it also
covers the OTC Pharmaceuticals Market in Latin America market landscape and
its growth prospects in the coming years. The report also includes a
discussion of the key vendors operating in this market.
Key vendors dominating this space include Bayer HealthCare AG., EMS S.A.,
Hypermarcas S.A., and Novartis AG.
Other vendors mentioned in the report are Boehringer Ingelheim GmbH., Genomma
Lab Internacional SAB., GlaxoSmithKline plc., Johnson & Johnson, Pfizer Inc.,
and Takeda Pharmaceutical Co. Ltd.
Key questions answered in this report:
- What will the market size be in 2018 and what will be the growth rate?
- What are key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by key vendors?
- What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst's time when you purchase this
market report. Details provided within the report.
Table of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
- 03.1. Market Overview
- 03.2. Product Offerings
04. Market Research Methodology
- 04.1. Market Research Process
- 04.2. Research Methodology
06. Market Landscape
- 06.1. Market Overview
- 06.2. Market Size and Forecast
- 06.3. Five Forces Analysis
07. Market Segmentation by Products
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
- 15.1. Competitive Scenario
- 15.1.1. Key News
- 15.1.2. Major Vendors
- 15.2. Other Prominent Vendors
16. Key Vendor Analysis
- 16.1. Bayer HealthCare AG
- 16.1.1. Business Overview
- 16.1.2. Business Segmentation
- 16.1.3. Key Information
- 16.1.4. SWOT Analysis
- 16.2. EMS S.A.
- 16.2.1. Business Overview
- 16.2.2. Business Segmentation
- 16.2.3. Key Information
- 16.2.4. SWOT Analysis
- 16.3. Hypermarcas S.A.
- 16.3.1. Business Overview
- 16.3.2. Business Segmentation
- 16.3.3. Key Information
- 16.3.4. SWOT Analysis
- 16.4. Novartis AG
- 16.4.1. Business Overview
- 16.4.2. Business Segmentation
- 16.4.3. Key Information
- 16.4.4. SWOT Analysis
17. Other Reports in this Series
List of Exhibits:
- Exhibit 1: Market Research Methodology
- Exhibit 2: OTC Pharmaceuticals Market in Latin America 2013-2018 (US$
- Exhibit 3: OTC Pharmaceuticals Market in Latin America by Product
- Exhibit 4: OTC Pharmaceuticals Market in Latin America Segmentation 2013
- Exhibit 5: Business Segmentation of Bayer HealthCare AG
- Exhibit 6: Business Segmentation of EMS S.A.
- Exhibit 7: Business Segmentation of Hypermarcas S.A.
- Exhibit 8: Business Segmentation of Novartis AG